Author

Luigi Taranto Montemurro

Brigham and Women's Hospital, Boston, MA, USA - Cited by 2,767 - Sleep apnea - genioglossus - OSA treatment - sleepiness - heart rate variability

Biography

Sleep Research Laboratory of the University Health Network Toronto Rehabilitation Institute, Toronto, Canada. Centre for sleep Medicine and Circadian Biology, University of Toronto, Toronto, Canada. Effect of an Anti-Supine Shirt for Treatment of Supine-related Obstructive Sleep Apnea
Title
Cited by
Year
The sleep apnea-specific hypoxic burden predicts incident heart failure
A Azarbarzin, SA Sands, L Taranto-Montemurro, D Vena, T Sofer, SW Kim, ...Chest 158 (2), 739-750, 2020202
81
2020
The sleep apnea–specific pulse-rate response predicts cardiovascular morbidity and mortality
A Azarbarzin, SA Sands, M Younes, L Taranto-Montemurro, T Sofer, ...American journal of respiratory and critical care medicine 203 (12), 1546-1555, 2021202
73
2021
Effects of the combination of atomoxetine and oxybutynin on OSA endotypic traits
L Taranto-Montemurro, L Messineo, A Azarbarzin, D Vena, LB Hess, ...Chest 157 (6), 1626-1636, 2020202
56
2020
Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial
E Perger, LT Montemurro, D Rosa, S Vicini, M Marconi, L Zanotti, ...Chest 161 (1), 237-247, 2022202
38
2022
Predicting sleep apnea responses to oral appliance therapy using polysomnographic airflow
D Vena, A Azarbarzin, M Marques, S Op de Beeck, OM Vanderveken, ...Sleep 43 (7), zsaa004, 2020202
37
2020
Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity
A Aishah, R Lim, SA Sands, L Taranto-Montemurro, A Wellman, ...Journal of Applied Physiology 130 (5), 1373-1382, 2021202
24
2021
Addition of zolpidem to combination therapy with atomoxetine‐oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A …
L Messineo, SG Carter, L Taranto‐Montemurro, A Chiang, A Vakulin, ...Respirology 26 (9), 878-886, 212
20
2021
Ventilatory drive withdrawal rather than reduced genioglossus compensation as a mechanism of obstructive sleep apnea in REM sleep
L Messineo, DJ Eckert, L Taranto-Montemurro, D Vena, A Azarbarzin, ...American journal of respiratory and critical care medicine 205 (2), 2-232, 2022202
19
2022
Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options
E Perger, L Taranto-MontemurroCurrent Opinion in Pulmonary Medicine 27 (6), 505-5, 2021202
13
2021
Neural ventilatory drive decline as a predominant mechanism of obstructive sleep apnoea events
LK Gell, D Vena, RM Alex, A Azarbarzin, N Calianese, LB Hess, ...Thorax 77 (7), 707-716, 2022202
12
2022
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility
L Messineo, L Taranto‐Montemurro, N Calianese, LK Gell, A Azarbarzin, ...Respirology 27 (), 975-982, 2022202
11
2022
Clinical polysomnographic methods for estimating pharyngeal collapsibility in obstructive sleep apnea
D Vena, L Taranto-Montemurro, A Azarbarzin, S Op de Beeck, M Marques, ...Sleep 45 (6), zsac050, 2022202
11
2022
Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA
R Rosenberg, B Abaluck, S TheinJournal of Clinical Sleep Medicine 18 (12), 2837-2844, 2022202
9
2022
Pathophysiology underlying demographic and obesity determinants of sleep apnea severity
SA Sands, RM Alex, D Mann, D Vena, PI Terrill, LK Gell, A Zinchuk, ...Annals of the American Thoracic Society 20 (3), 440-44, 2023202
9
2023
Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: a pilot randomized controlled trial
L Taranto‐Montemurro, S Sands, A Azarbarzin, N Calianese, D Vena, ...Respirology 2 (5), 485-492, 2021202
6
2021
Inverse relationship of subjective daytime sleepiness to mortality in heart failure patients with sleep apnoea
T Kasai, L Taranto Montemurro, D Yumino, H Wang, JS Floras, ...ESC Heart Failure 7 (), 2448-244, 2020202
5
2020
P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
A Aishah, K Loffler, B Tonson, S Mukherjee, R Adams, T Altree, ...Sleep Advances 2 (Supplement_1), A22-A22, 2021202
4
2021
Night-to-night variability of polysomnography-derived physiologic endotypic traits in patients with moderate to severe OSA
C Strassberger, J Hedner, SA Sands, TM Tolbert, L Taranto-Montemurro, ...Chest 163 (5), 1266-1278, 2023202
4
2023
The combination of betahistine and oxybutynin increases respiratory control sensitivity (loop gain) in people with obstructive sleep apnea: a randomized, placebo-controlled trial
L Messineo, K Loffler, A Chiang, A Osman, L Taranto-Montemurro, ...Nature and Science of Sleep, 106-1074, 2022202
3
2022
Methods and compositions for treating sleep apnea
DA Wellman, L Taranto-MontemurroUS Patent 11,12,1, 2021202
3
2021

Referred From: https://scholar.google.it/citations?user=jfMFFo4AAAAJ&hl=it

Cited by
Citations 2767
h-index 29
i10-index 53
Recommended Journals
Open Access Journals